Lyondell Chemical Co - Current report filing (8-K)
21 November 2007 - 2:38AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of
Report (date of earliest event reported): November 20, 2007
LYONDELL
CHEMICAL COMPANY
(Exact
name of registrant as specified in its charter)
Delaware
(State
or
other jurisdiction of incorporation)
1-10145
(Commission
File Number)
|
95-4160558
(I.R.S.
Employer Identification No.)
|
|
|
1221
McKinney Street, Suite 700, Houston, Texas
(Address
of principal executive offices)
|
77010
(Zip
Code)
|
(713)
652-7200
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (
see
General Instruction A.2. below):
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
8.01 Other Events
Lyondell
Chemical Company (“Lyondell”) held a special meeting of its shareholders on
November 20, 2007. At the special shareholder meeting, each of the
following proposals was approved by Lyondell’s shareholders:
1.
|
approve
and adopt the Agreement and Plan of Merger, dated as of July 16,
2007, among Basell AF, BIL Acquisition Holdings Limited and Lyondell,
as
such agreement may be amended from time to
time.
|
2.
|
adjourn
the special meeting, if necessary, to solicit additional proxies
if there
are insufficient votes at the time of the special meeting to approve
and
adopt the merger agreement.
|
The
votes, as tabulated by the independent inspector of elections, were as
follows:
1. Approval
and Adoption of Merger Agreement:
|
|
|
For:
|
|
166,895,281
|
|
|
|
|
Against:
|
|
747,927
|
|
|
|
|
Abstain:
|
|
365,305
|
|
|
|
|
Broker
Non-Votes:
|
|
0
|
|
|
|
2. Adjournment
Proposal:
|
|
|
For:
|
|
156,544,739
|
|
|
|
|
Against:
|
|
11,049,706
|
|
|
|
|
Abstain:
|
|
414,068
|
|
|
|
|
Broker
Non-Votes:
|
|
0
|
|
|
The
press
release regarding this matter is being filed with this Current Report on Form
8-K as Exhibit 99.1.
Item
9.01 Financial
Statements and Exhibits
(d) Exhibits.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
LYONDELL
CHEMICAL COMPANY
By:
/s/
Kerry A. Galvin
Name: Kerry
A. Galvin
Title: Senior
Vice President and
General
Counsel
Date: November
20, 2007
INDEX
TO EXHIBITS
Exhibit
Number
Description
Lyondell (NYSE:LYO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Lyondell (NYSE:LYO)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Lyondell Chemical (New York Stock Exchange): 0 recent articles
More Lyondell Chemical Co News Articles